Support for two increased vasopressinergic activities in depression at large and the differential effect of antidepressant treatment

Journal of Psychopharmacology

Volumn 25, Issue 10, 2011, Pages 1304-1312

  Goekoop, J G ^a,b   De Winter, R F P ^c   Wolterbeek, R ^a   Wiegant, V M ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Location Oegstgeest ^*  (Netherlands)

^c Parnassia Bavogroup   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antidepressant treatment; cortisol; depression; sexual dimorphism; V1b receptor; vasopressin

Indexed keywords

ANTIDEPRESSANT AGENT; ARGIPRESSIN; ARGIPRESSIN RECEPTOR; BENZODIAZEPINE; HYDROCORTISONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG ACTIVITY; DRUG RESPONSE; FEMALE; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; VASOPRESSIN RELEASE;

ADULT; ANTIDEPRESSIVE AGENTS; ARGININE VASOPRESSIN; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; RECEPTORS, VASOPRESSIN;

EID: 79955122261     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110372549     Document Type: Article

References (46)

1. Aguilera G, Subburaju S, Young S, Chen J. The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress. Prog Brain Res. 2008 ; 170: 29-39 (Pubitemid 352010218)
2. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Press ; 1994 :
3. Brunner J, Keck ME, Landgraf R, Uhr M, Namendorf C, Bronisch T. Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results. Eur Neuropsychopharmacol. 2002 ; 12: 489-494
4. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993 ; 50: 975-990 (Pubitemid 23361478)
5. Dempster EL, Burcescu I, Wigg K, Kiss E, Baji I, Gadoros J, et al. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. Arch Gen Psychiatry. 2007 ; 64: 1189-1195 (Pubitemid 47529343)
6. Dempster EL, Burcescu I, Wigg K, Kiss E, Baji I, Gadoros J, et al. Further genetic evidence implicates the vasopressin system in childhood-onset mood disorders. Eur J Neurosci. 2009 ; 30: 1615-1619
7. De Winter RF, van Hemert AM, DeRijk RH, Zwinderman KH, Frankhuijzen-Sierevogel AC, Wiegant VM, et al. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology. 2003 ; 28: 140-147
8. De Winter RF, Wolterbeek R, Spinhoven P, Zitman FG, Goekoop JG. Character and temperament in major depressive disorder and a highly anxious-retarded subtype derived from melancholia. Compr Psychiatry. 2007 ; 48: 426-435 (Pubitemid 47247430)
9. De Winter RF, Zitman FG, van Houwelingen JC, Wolterbeek R, Goekoop JG. Anxious-retarded depression: relation to two-year outcome of major depressive disorder. J Affect Disord. 2006 ; 90: 77-81 (Pubitemid 43005042)
10. De Winter RF, Zwinderman KH, Goekoop JG. Anxious-retarded depression: relation to family history of depression. Psychiatry Res. 2004 ; 127: 111-119 (Pubitemid 38916872)
11. Dinan TG, O'Brien S, Lavelle E, Scott LV. Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression. Psychol Med. 2004 ; 34: 169-172 (Pubitemid 38139452)
12. Engelmann M, Landgraf R, Wotjak CT. The hypothalamic-neurohypophyseal system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept revisited. Front Neuroendocrinol. 2004 ; 25: 132-149 (Pubitemid 39626771)
13. Goekoop JG Vasopressinerge mechanismen bij affectieve stoornissen. Van Gerven JMA Van der Post J Zitman FG, ed. Leiden: Boerhaave Commissie voor Postacademisch Onderwijs in de Geneeskunde ; 2009: 1-11.
14. Goekoop JG, de Winter RP, de Rijk R, Zwinderman KH, Frankhuijzen- Sierevogel A, Wiegant VM. Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation. Psychiatry Res. 2006 ; 141: 201-211
15. Goekoop JG, de Winter RFP, Wolterbeek R, Spinhoven Ph , Zitman FG, Wiegant VM. Reduced cooperativeness and reward-dependence in depression with above-normal plasma vasopressin concentration. J Psychopharmacol. 2009a ; 23: 891-897
16. Goekoop JG, de Winter RFP, Wolterbeek R, Van Kempen GMJ, Wiegant VM. Evidence of vasopressinergic-noradrenergic mechanisms in depression with above-normal plasma vasopressin concentration with and without psychotic features. J Psychopharmacol. 2009b ;:
17. Goekoop JG, Hoeksema T, Van Kempen GM, Van der Velde EA, Spies F. Osmotic behavior of erythrocytes from patients with a major affective disorder. A freeze-fracture electron microscopic study. J Affect Disord. 1990 ; 19: 139-147 (Pubitemid 20178783)
18. Goekoop JG, Wiegant VM. Support for two subcategories of depression with different vasopressinergic mechanisms in the field of melancholia. Curr Psych Rev. 2009 ; 5: 127-136
19. Griebel G, Stemmelin J, Gal CS, Soubrie P. Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders. Curr Pharm Des. 2005 ; 11: 1549-1559 (Pubitemid 40691451)
20. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. Cortisol secretion in endogenous depression. I. Basal plasma levels. Arch Gen Psychiatry. 1985 ; 42: 904-908 (Pubitemid 16248516)
21. Hoeksema T, Goekoop JG, Van Kempen GM. Hypertonic hemolysis in patients with a mood disorder. Biol Psychiatry. 1996 ; 39: 11-15 (Pubitemid 26022679)
22. Inder WJ, Donald RA, Prickett TC, Frampton CM, Sullivan PF, Mulder RT, et al. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol Psychiatry. 1997 ; 42: 744-747 (Pubitemid 27444511)
23. Jezova D, Skultetyova I, Tokarev DI, Bakos P, Vigas M. Vasopressin and oxytocin in stress. Ann N Y Acad Sci. 1995 ; 771: 192-203 (Pubitemid 26077407)
24. Kalisch R, Salome N, Platzer S, Wigger A, Czisch M, Sommer W, et al. High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats. Neuroimage. 2004 ; 23: 382-391 (Pubitemid 39119469)
25. Keck ME, Welt T, Muller MB, Uhr M, Ohl F, Wigger A, et al. Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology. 2003 ; 28: 235-243
26. Keck ME, Wigger A, Welt T, Muller MB, Gesing A, Reul JM, et al. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology. 2002 ; 26: 94-105 (Pubitemid 34075280)
27. Kerry RJ, Owen G, Griffiths H, Randall ZC, Davies HM. Changes in body water, weight and electrolytes in recurrent mental illness. Dis Nerv Syst. 1968 ; 29: 328-332
28. Landgraf R. The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets. 2006 ; 5: 167-179 (Pubitemid 43796618)
29. Landgraf R, Wigger A, Holsboer F, Neumann ID. Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour. J Neuroendocrinol. 1999 ; 11: 405-407 (Pubitemid 29243762)
30. Meynen G, Unmehopa UA, van Heerikhuize JJ, Hofman MA, Swaab DF, Hoogendijk WJ. Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report. Biol Psychiatry. 2006 ; 60: 892-895 (Pubitemid 44527884)
31. Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav. 2007 ; 51: 395-405 (Pubitemid 46365691)
32. Moleman P, Birkenhaeger TK Praktische psychofarmacologie. Houten: Bohn Stafleu Van Loghum ; 1998 :
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979 ; 134: 382-389 (Pubitemid 9136500)
34. Nikisch G. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuro Endocrinol Lett. 2009 ; 30: 11-16
35. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry. 1996 ; 53: 137-143 (Pubitemid 26050037)
36. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 1994 ; 60: 436-444 (Pubitemid 24284827)
37. Salome N, Viltart O, Lesage J, Landgraf R, Vieau D, Laborie C. Altered hypothalamo-pituitary-adrenal and sympatho-adrenomedullary activities in rats bred for high anxiety: central and peripheral correlates. Psychoneuroendocrinology. 2006 ; 31: 724-735 (Pubitemid 44262254)
38. Stewart LQ, Roper JA, Scott YW, O'Carroll AM, Lolait SJ. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants. Psychoneuroendocrinology. 2008 ; 33: 405-415
39. Swaab DF, Fliers E, Hoogendijk WJ, Veltman DJ, Zhou JN. Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. Prog Brain Res. 2000 ; 126: 369-396 (Pubitemid 35461301)
40. Van Londen L (2003) Vasopressin in Major Depression. Thesis/Dissertation, Leiden University.
41. Van Londen L, Goekoop JG, van Kempen GM, Frankhuijzen-Sierevogel AC, Wiegant VM, van der Velde EA, et al. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology. 1997 ; 17: 284-292 (Pubitemid 27440650)
42. Van Londen L, Kerkhof GA, van den BF, Goekoop JG, Zwinderman KH, Frankhuijzen-Sierevogel AC, Wiegant VM, et al. Plasma arginine vasopressin and motor activity in major depression. Biol Psychiatry. 1998 ; 43: 196-204 (Pubitemid 28096557)
43. Wigger A, Sanchez MM, Mathys KC, Ebner K, Frank E, Liu D, et al. Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology. 2004 ; 29: 1-14 (Pubitemid 38068008)
44. Williams TD, Carter DA, Lightman SL. Sexual dimorphism in the posterior pituitary response to stress in the rat. Endocrinology. 1985 ; 116: 738-740 (Pubitemid 15165876)
45. Wotjak CT, Ludwig M, Ebner K, Russell JA, Singewald N, Landgraf R, et al. Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion. Eur J Neurosci. 2002 ; 16: 477-485 (Pubitemid 35471866)
46. Zimmermann U, Spring K, Wittchen HU, Himmerich H, Landgraf R, Uhr M, et al. Arginine vasopressin and adrenocorticotropin secretion in response to psychosocial stress is attenuated by ethanol in sons of alcohol-dependent fathers. J Psychiatr Res. 2004 ; 38: 385-393